Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Proof of Concept Single-arm Study Using PuraStat Following the Aquablation Procedure to Assess Reduction of Hematuria to Allow for Same Day Discharge

NCT06948331 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06948331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06948331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Proof of Concept Single-arm Study Using PuraStat Following the Aquablation Procedure to Assess Reduction of Hematuria to Allow for Same Day Discharge
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
August 1, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, hematuria, lower urinary tract symptoms